What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received ...

By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...

June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that ...

A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, ...

Domenico wrote that drug pricing is remarkable for its "puzzling opacity," but added that it is "not necessary to unravel the ...

If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...

Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate ...

Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...

View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

The tablets involved in the recall were distributed in the U.S. from Oct. 28, 2021, to Dec. 30, 2025 ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...